|Min SIP Amount||Not Supported|
|NAV||₹273.52 (25 Sep 2020)|
|Fund Started||04 Aug 2017|
|Fund Size||₹362 Cr|
|Divi's Laboratories Ltd.||Healthcare||Equity||5.4%|
|Avenue Supermarts Ltd.||Services||Equity||4.5%|
|SBI Life Insurance Company Ltd.||Financial||Equity||4.4%|
|Dabur India Ltd.||FMCG||Equity||3.6%|
|ICICI Lombard General Insurance Company Ltd.||Financial||Equity||3.4%|
|Godrej Consumer Products Ltd.||FMCG||Equity||3.3%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||3.1%|
|Info Edge (India) Ltd.||Services||Equity||3.1%|
|Pidilite Industries Ltd.||Chemicals||Equity||2.9%|
UTI Nifty Next 50 Exchange Traded Fund Regular Growth is a Others Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 04 Aug 2017. Kaushik Basu is the Current Fund Manager of UTI Nifty Next 50 Exchange Traded Fund Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹362 Cr and the Latest NAV as of 25 Sep 2020 is ₹273.52.
The UTI Nifty Next 50 Exchange Traded Fund Regular Growth is rated Moderately High risk.
The scheme seeks to provide returns that, before expenses, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.